Discover 572 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma City offers many opportunities for both healthy volunteers and individuals with specific health concerns to participate in clinical research. Participants have the opportunity to explore innovative treatments and contribute to the advancement of medical science for conditions such as depression, pulmonary fibrosis, and various neurological disorders.
Filter
2
Filter results
Results: 572
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
for
Mitral Regurgitation, Mitral Valve Disease,
Location: Oklahoma City OK, Houston TX, Minneapolis MN, Tucson AZ,
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Sex: All
Age: 18+
Code: NCT04688190
Recruiting
Radial vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
Location: Oklahoma City OK, Fort Smith AR, Forth Worth TX,
Sponsor: Elephas
Sex: All
Age: 18+
Code: NCT07327489
Recruiting
Acellular Dermal Matrix Investigation in Breast Reconstruction
for
Breast Reconstruction
Location: Oklahoma City OK, Lawrence KS, Little Rock AR,
Sponsor: RTI Surgical
Sex: Female
Age: 22+
Code: NCT06456554
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Oklahoma City OK, Richardson TX, Fort Smith AR,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase 3, Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Oklahoma City OK, Fort Smith AR, Joplin MO,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase 3, Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
for
Pancreatic Acinar Cell Carcinoma,
Location: Oklahoma City OK, Richardson TX, Dallas TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04858334
Phase 2, Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Oklahoma City OK, Fort Smith AR, Joplin MO,